Summary
This prediction ended on 26.10.21 with a price of €80,000. The prediction had a final performance of 11.11%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Neovacs | - | - | - | - |
| iShares Core DAX® | -1,66 % | -10,87 % | -0,72 % | 41,87 % |
| iShares Nasdaq 100 | -3,77 % | -5,15 % | 13,41 % | 70,29 % |
| iShares Nikkei 225® | -2,80 % | -11,30 % | 25,46 % | 45,96 % |
| iShares S&P 500 | -2,30 % | -4,80 % | 8,94 % | 54,18 % |
According to melinda what are the pros and cons of Neovacs for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year